Metropolitan Digital

Google


.

Parents in the US had alarmingly high rates of anxiety and depression during the COVID-19 pandemic – and that has a direct effect on kids

  • Written by Lucy (Kathleen) McGoron, Assistant Professor of Child and Family Development, Wayne State University
Parents in the US had alarmingly high rates of anxiety and depression during the COVID-19 pandemic – and that has a direct effect on kidsThe mental health of parents and children are often intertwined.Goodboy Picture Company/E+ via Getty Images

It’s no secret that the COVID-19 pandemic has taken a heavy toll on the mental health of kids and parents alike.

In a 2020 survey, 71% of parents said they believed the pandemic had hurt their children’s mental health. The American...

Read more: Parents in the US had alarmingly high rates of anxiety and depression during the COVID-19 pandemic...

More Articles ...

  1. Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works
  2. New Israeli power broker seeks to rewrite history to justify violence against Palestinians
  3. Allegations that the charity George Santos claims to have run was fake highlight how scams divert money from worthy causes
  4. Plans for deep seabed mining pit renewable energy demand against ocean life in a largely unexplored frontier
  5. Stopping the cancer cells that thrive on chemotherapy – research into how pancreatic tumors adapt to stress could lead to a new treatment approach
  6. 'The most dangerous Negro': 3 essential reads on the FBI's assessment of MLK's radical views and allies
  7. Voters have few options to remove George Santos from Congress – aside from waiting until the next election
  8. Special counsels, like those examining Biden's and Trump's handling of classified documents, are intended to be independent – but they aren't entirely
  9. Marriage provides health benefits – and here's why
  10. What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab